Latest Breaking News On - Suven life sciences limited stock exchange - Page 1 : comparemela.com

Suven Life Sciences announces two poster presentations including patient baseline characteristics and demographics from the phase-2 Proof of Concept study on samelisant at. | June 3, 2023

United statesResearch societyAmerican academy of sleep medicineSuven life sciencesOur companyAbout sleepAssociated professional sleep societiesAmerican academySleep medicineSleep research societyMajor depressive disorderAttention deficient hyperactivity disorderLife sciencesSuven life sciences limited stock exchangePress releaseAmelisant 530239 ine495b01038